BMS-502

N/A

Report date: 2023/11/01 16:46:31
NME

Base Information

Drug NameBMS-502
Drug Alias NameBMS-502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol kinase alpha inhibitorsDiacylglycerol kinase zeta inhibitors
TargetsDiacylglycerol kinase alphaDiacylglycerol kinase zeta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A